Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

CS12192 effectively treats alopecia areata with better safety than current options.